Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population

Young Hoon Cho; Ju Whi Kim; Jung Ok Shim; Hye Ran Yang; Ju Young Chang; Jin Soo Moon; Jae Sung Ko

doi:10.5223/pghn.2019.22.3.233

Journal List > Pediatr Gastroenterol Hepatol Nutr > v.22(3) > 1121975

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Cho, Kim, Shim, Yang, Chang, Moon, and Ko: Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population

Original Article

Pediatric Gastroenterology, Hepatology & Nutrition 2019; 22(3): 233-241.

Published online: 16 April 2019

DOI: https://doi.org/10.5223/pghn.2019.22.3.233

Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population

Young Hoon Cho¹, Ju Whi Kim¹, Jung Ok Shim², Hye Ran Yang¹, Ju Young Chang¹, Jin Soo Moon¹, Jae Sung Ko¹

¹Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.

²Department of Pediatrics, Korea University Medical Center, Seoul, Korea.

Correspondence to Jae Sung Ko. Department of Pediatrics, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea. kojs@snu.ac.kr

Received 27 August 2018 Revised 21 September 2018 Accepted 27 September 2018

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition

(open-access):

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

Vitamin D deficiency is a condition widespread throughout the world. Recent studies have suggested that vitamin D deficiency was associated with obesity and metabolic syndrome. The purpose of the study was to examine the relationship between vitamin D deficiency and nonalcoholic fatty liver disease (NAFLD) in adolescents.

Methods

The data were obtained from the Korean National Health and Nutrition Examination Survey from 2008–2014. A total of 3,878 adolescents were included in the study. Vitamin D deficiency was defined as a 25-hydroxyvitamin D concentration <20 ng/mL and suspected NAFLD was defined as an alanine transaminase concentration >30 U/L.

Results

Vitamin D deficiency was noted in 78.9% of the studied population. Age, body mass index, waist circumference, and blood pressure, glucose, cholesterol, and triglyceride levels were significantly higher in adolescents with suspected NAFLD than in adolescents without suspected NAFLD, while the mean vitamin D level was significantly lower in adolescents with suspected NAFLD. The multivariate-adjusted odds of suspected NAFLD were higher with increased age, male gender, obesity, and metabolic syndrome. Individuals with vitamin D deficiency were at higher risk of suspected NAFLD (odds ratio, 1.77; 95% confidence interval, 1.07–2.95) after adjusting for age, gender, obesity, and metabolic syndrome.

Conclusion

Vitamin D deficiency was associated with suspected NAFLD, independent of obesity and metabolic syndrome, in adolescents.

Keywords: Vitamin D deficiency, Nonalcoholic fatty liver disease, Alanine transaminase, Adolescent, Children, Obesity

INTRODUCTION

Vitamin D deficiency is highly prevalent and has become an important health concern among Korean adolescents [1]. Vitamin D status has traditionally been considered an important factor in calcium-associated metabolism. In addition, recent attention has focused on the extra-skeletal effects of vitamin D [2] and increasing evidence has shown that low serum vitamin D levels were associated with obesity and metabolic syndrome [3 4 5].

Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disease in adolescents and its prevalence has risen substantially in recent decades [6]. Several different parallel processes participate in the development of NAFLD [7] and many potential risk factors for NAFLD, including obesity, insulin resistance, and metabolic syndrome, have been identified. Vitamin D deficiency has been investigated as a risk factor for the development of NAFLD and several studies have suggested that vitamin D levels were inversely associated with NAFLD in adults [8 9 10 11]. However, few studies have investigated the relationship between vitamin D deficiency and NAFLD in an adolescent population [12].

This study aimed to elucidate the association between vitamin D deficiency and suspected NAFLD in adolescents using nationally-representative cross-sectional data after adjusting for obesity and metabolic syndrome.

MATERIALS AND METHODS

The Korean National Health and Nutrition Examination Survey (KNHANES), a South Korean national survey program conducted by the Korea Centers for Disease Control and Prevention, is an ongoing time-series cross-sectional and nationally-representative survey. The KNHANES obtains information using standardized health interviews, health examinations, and nutrition surveys. The data are collected annually from a complex, multistage, stratified, clustered probability sample, representative of the general Korean population [13]. The data on adolescents aged 12–18 years who participated in the KNHANES 2008–2014 (KNHANES IV–VI) were concatenated into one database.

The survey included 5,398 adolescents aged 12–18 years and 3,936 of the adolescents provided vitamin D blood samples. We excluded 44 adolescents with missing data on any relevant factors, as well as fourteen adolescents who were positive for hepatitis B surface antigen. As a result, 3,878 subjects were analyzed. Data regarding age, gender, body mass indexes (BMIs), systolic blood pressure (SBP), diastolic blood pressure (DBP), and waist circumferences were evaluated, as were data regarding glucose, cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), alanine transaminase (ALT), and vitamin D levels.

Suspected NAFLD was defined as a serum ALT level >30 U/L. Population studies have used serum ALT concentrations >30 U/L as surrogate markers for NAFLD in adolescents [12 14]. The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines for NAFLD suggest an ALT concentration >22 U/L for girls and >26 U/L for boys as a screening test for NAFLD [15]. Vitamin D levels were determined by measuring the level of serum 25-hydroxyvitamin D (25(OH)D), which reflects the vitamin D obtained by cutaneous synthesis and nutritional intake [2]. Serum 25(OH)D levels were measured by radioimmunoassay at the Neodyne Medical Research Laboratories and vitamin D deficiency was defined as a 25(OH)D concentration <20 ng/mL [2]. Anthropometric measurements were performed by medical staff according to a standardized protocol. Body weight, height, and waist circumference were measured to the nearest 0.1 kg, 0.1 cm, and 0.1 cm, respectively. Blood pressure was measured three times in the right arm and the final blood pressure value was obtained by averaging the second and third measurements. BMI was calculated using weight and height, and obesity was defined as a BMI ≥the 95th percentile for age and gender [16]. Data on adolescent BMI and waist circumference percentiles were obtained from the 2007 Korean National Growth Charts [17]. Metabolic syndrome was defined using the adolescent-specific criteria of the International Diabetes Federation and was diagnosed in adolescents with central obesity plus two or more of the other components or adolescents with four more of the other components [18].

This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 1712-097-907). All participants provided informed consent.

Statistical analyses

Statistical analyses were carried out using SPSS software version 23.0 (IBM Corp., Armonk, NY, USA). We analyzed the risk factors for NAFLD using the Student's t-test (continuous variables) or χ² tests (categorical variables). Continuous variables were reported as the mean±standard error and categorical variables were reported as counts and percentages. Univariate logistic regression analyses were conducted to identify the predictors of suspected NAFLD. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using adjusted sample weights for the study population. Multivariate logistic regression analysis was used to analyze the association between vitamin D deficiency and suspected NAFLD after adjustment for all predictors that showed a significant association with suspected NAFLD in the univariate analysis. Sample weights were included in the analysis to account for the differential probabilities of selection, nonresponse, and noncoverage. Density plots for log-transformed ALT levels were generated using the R statistical package (R Foundation, Vienna, Austria). The p-values <0.05 were considered statistically significant.

RESULTS

The weighted and standardized prevalence of suspected NAFLD was 6.0 percent. Vitamin D deficiency was noted in 78.9% of the Korean adolescents. The prevalence of obesity and metabolic syndrome was 7.2% and 2.0%, respectively.

Table 1 shows the baseline participant characteristics according to the presence or absence of suspected NAFLD. Age, BMIs, waist circumferences, SBP levels, and DBP levels, as well as glucose, cholesterol, and TG levels, were higher in adolescents with suspected NAFLD than in adolescents without suspected NAFLD. HDL-C levels were negatively associated with suspected NAFLD. Adolescents with suspected NAFLD had significantly lower 25(OH)D levels than adolescents without suspected NAFLD (14.92±0.33 vs. 16.28±0.15 ng/mL, p<0.001). Male gender, obesity, metabolic syndrome, and vitamin D deficiency were positively associated with suspected NAFLD.

Table 1

Baseline characteristics of the participants according to the presence or absence of suspected nonalcoholic fatty liver disease

Characteristics	ALT ≤30 U/L	ALT >30 U/L	p-value^*
No. of participants	3,663	215
Age (yr)	15.09±0.04	15.73±0.16	<0.001
Male	1,892 (52.0)	178 (82.8)	<0.001
BMI (kg/m²)	20.87±0.07	26.16±0.34	<0.001
Waist circumference (cm)	70.12±0.18	85.11±0.96	<0.001
SBP (mmHg)	107.30±0.23	115.74±0.94	<0.001
DBP (mmHg)	67.54±0.19	71.61±0.86	<0.001
FBG (mg/dL)	89.01±0.17	90.53±0.63	0.019
Cholesterol (mg/dL)	154.66±0.58	173.58±2.88	<0.001
HDL-C (mg/dL)	50.16±0.21	46.00±0.86	<0.001
TG (mg/dL)	82.14±0.99	126.58±6.86	<0.001
Vitamin D (ng/mL)	16.28±0.15	14.92±0.33	<0.001
Obesity	181 (5.3)	80 (36.5)	<0.001
Metabolic syndrome	39 (1.2)	31 (14.0)	<0.001
Vitamin D deficiency	2,835 (78.3)	183 (87.2)	0.006

Categorical variables are shown as unweighted numbers of people and weighted percentages number (%), and continuous variables are shown as weighted means±standard errors in each group.

ALT: alanine transaminase, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, FBG: fasting blood glucose, HDL-C: high density lipoprotein cholesterol.

^*Categorical variables were analyzed by Pearson χ² tests, and continuous variables were analyzed by Student's t-test.

We generated a density plot to show the relationship between vitamin D deficiency and ALT levels. Because the serum ALT levels were log-normally distributed, we converted them into a log form, designated log_eALT. The density plot was drawn by dividing the vitamin D-deficient and non-vitamin D-deficient adolescents into separate groups (Fig. 1). Vitamin D deficiency was more prevalent in adolescents with ALT levels above 30 U/L.

Fig. 1

The density plot of log-transformed ALT levels in adolescents according to the presence or absence of vitamin D deficiency. Vitamin D deficiency is more prevalent in adolescents with ALT levels above 30 U/L (p<0.01).

ALT: alanine transaminase.

We performed univariate and multivariate logistic regression analyses in which suspected NAFLD served as a dependent variable (Table 2). Univariate analysis showed that older age, male gender, obesity, metabolic syndrome, and vitamin D deficiency were significantly associated with suspected NAFLD and age- and gender-adjusted analysis showed that suspected NAFLD was significantly associated with obesity, metabolic syndrome, and vitamin D deficiency. Multivariate logistic regression analysis showed that increased age (OR, 1.17; 95% CI, 1.05–1.30) and male gender (OR, 5.63; 95% CI, 3.59–8.84) were independent determinants of the risk of suspected NAFLD. Obese adolescents were 8.29 times more likely to have suspected NAFLD than non-obese adolescents (95% CI, 5.24–13.12). Metabolic syndrome was independently associated with suspected NAFLD (OR, 3.86; 95% CI, 1.83–8.14). Adolescents with vitamin D deficiency were at higher risk for suspected NAFLD than adolescents without vitamin D deficiency (OR, 1.77; 95% CI, 1.07–2.95). Vitamin D deficiency in adolescents was also independently associated with suspected adolescent NAFLD when the NASPGHAN guideline for NAFLD was applied.

Table 2

Unadjusted, age- and gender-adjusted, and multivariate-adjusted ORs and CIs for suspected nonalcoholic fatty liver disease

Variables	Univariate		Age-, gender-adjusted		Multivariate
Variables	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value
Age	1.19 (1.09–1.31)	<0.001	-	-	1.17 (1.05–1.30)	0.004
Male	4.44 (2.93–6.72)	<0.001	-	-	5.63 (3.59–8.84)	<0.001
Obesity	10.31 (7.16–14.84)	<0.001	11.77 (7.96–17.41)	<0.001	8.29 (5.24–13.12)	<0.001
Metabolic syndrome	13.52 (7.45–24.54)	<0.001	17.54 (9.11–33.76)	<0.001	3.86 (1.83–8.14)	<0.001
Vitamin D deficiency	1.88 (1.19–2.98)	0.007	1.94 (1.20–3.12)	0.006	1.77 (1.07–2.95)	0.028

OR: odds ratio, CI: confidence interval.

DISCUSSION

The prevalence of vitamin D deficiency was 78.9% in the present study. In the United States (US) National Health and Nutrition Examination Survey 2001–2006, the prevalence of vitamin D deficiency in adolescent boys and girls was 28.1% and 34.3%, respectively [19]. In the KNHANES 2008–2009, vitamin D deficiency was noted in 75.3% of Korean adolescents, a finding similar to ours [20]. These results suggest that vitamin D deficiency was more prevalent in Korean adolescents than in US adolescents. The low vitamin D levels of Korean adolescents may be attributed to the enormous amounts of time that these individuals spend studying for their university entrance examinations and the limited amounts of time engaged in outdoor activities [21]. The prevalence of suspected NAFLD, defined as a serum ALT concentration >30 U/L, was 6.0% in Korean adolescents. The prevalence of suspected NAFLD was 8.4% in US adolescents 12–19 years of age [12]. A recent study showed that the prevalence of NAFLD in Korean adolescents 10–18 years of age did not change between 2001 and 2014 [22].

In this study, multivariate logistic regression analysis revealed that increased age, male gender, obesity, metabolic syndrome, and vitamin D deficiency were independently associated with suspected NAFLD. Our findings are supported by a prior study [14] showing that increased age and male gender were associated with suspected NAFLD in US adolescents. Among the independent correlates, obesity was the most serious risk factor for suspected NAFLD. The prevalence of obesity and metabolic syndrome is rapidly increasing in adults and adolescents [23]. Dysregulated adipokine production caused by excess adipose tissue triggers chronic low-grade inflammation and enhances insulin resistance [7 24], an integral feature of metabolic syndrome. NAFLD has been regarded as the liver manifestation of metabolic syndrome [25]. Our data revealed an adjusted OR of 3.86 for the association between metabolic syndrome and suspected NAFLD in adolescents. Previous studies have also demonstrated this strong association, with metabolic syndrome being more prevalent in Korean and US adolescents with suspected NAFLD than in Korean and US adolescents without suspected NAFLD [26 27]. In addition, metabolic syndrome was positively associated with the severity of NAFLD in children [28].

Vitamin D levels were inversely associated with obesity, insulin resistance, and metabolic syndrome [3 4]. Therefore, obesity and metabolic syndrome might confound the association between vitamin D deficiency and NAFLD. In this study, we controlled for obesity and metabolic syndrome as confounding variables. We demonstrated for the first time that vitamin D deficiency was significantly associated with suspected NAFLD in adolescents after adjustment for obesity and metabolic syndrome.

Several studies have shown that serum vitamin D levels were related to NAFLD. Adult population-based studies have noted that low vitamin D levels were independently related to NAFLD [8 9 10 11] and a study of Korean adults showed that vitamin D deficiency was significantly related to NAFLD in men but not in women [29]. However, serum vitamin D levels were not significantly associated with NAFLD in a Chinese adult population [30]. A meta-analysis including nine studies demonstrated that the risk of vitamin D deficiency was 26% higher in subjects with NAFLD than in control subjects [31]. Low vitamin D levels were independently associated with liver biopsy-proven NAFLD in adolescents [32]. In another study, low vitamin D levels were not found to be an independent predictor of suspected NAFLD in 1,630 adolescents after adjusting for obesity [12]. Our study had a relatively larger sample size than the US study and was adjusted for metabolic syndrome, in addition to obesity.

The mechanisms underlying the association between low vitamin D levels and NAFLD are largely unknown. Some studies have revealed that low vitamin D levels decreased insulin sensitivity and impaired beta cell function [33], suggesting that low vitamin D levels participate in the development of NAFLD by increasing insulin resistance. However, the finding that vitamin D deficiency was independently associated with suspected NAFLD after adjusting for metabolic syndrome, a phenotypic marker of insulin resistance, suggested that vitamin D was directly involved in the development of NAFLD. In rats exposed to a Westernized diet, low vitamin D levels led to the aggravation of hepatic steatosis and lobular inflammation. Low vitamin D levels also led to an increase in markers of the Toll-like receptor signaling pathway, suggesting that low vitamin D levels can lead to hepatic steatosis by activating Toll-like receptors and downstream inflammatory signaling molecules [34]. In rat models of diet-induced and obesity-related nonalcoholic steatohepatitis, nonalcoholic steatohepatitis progression, but not obesity progression, was attenuated by phototherapy, suggesting that vitamin D had anti-inflammatory activity, rather than anti-obesity activity [35].

In addition, a lack of outdoor activities in children with obesity can be another cause of vitamin D deficiency. For decades, the prevalence of obesity has been rapidly increasing, while physical activities, such as active transport or physical education in school, have decreased in children [36 37] and many studies have shown that obesity was associated with lower levels of physical activity and more screen media exposure in school-aged children [38 39]. In this regard, reducing screen time and increasing outdoor activities should be recommended for children with obesity and vitamin D deficiencies.

Our findings regarding the relationship between vitamin D deficiency and NAFLD suggest that taking vitamin D supplements represents a therapeutic option for patients with NAFLD. Hepatic steatosis severity was found to significantly improve after four weeks of vitamin D supplementation [40]. Additional studies are required to determine the therapeutic effects of vitamin D supplementation on NAFLD in adolescents.

The major strength of this study was that it is the first nationally-representative study outside the West to show an association between vitamin D deficiency and suspected NAFLD in adolescents. We conducted the analysis over a 7-year time period using composite stratified extraction and sample weights representative of the Korean adolescent population. This study was also the first to investigate the association between vitamin D deficiency and NAFLD in adolescents after adjusting for obesity and metabolic syndrome.

This study had some limitations. First, the diagnosis of NAFLD was not confirmed by liver biopsy. The gold standard for the diagnosis of NAFLD is a liver biopsy, however, the procedure was not feasible in this population study. Elevated ALT levels are widely accepted biomarkers for NAFLD in population-based studies [11 12 14 26]. The main purpose of this study was to reveal the association between vitamin D deficiency and suspected NAFLD, rather than to assess the prevalence of suspected NAFLD. Second, whether a causal relationship exists between vitamin D and NAFLD could not be determined from this observational, cross-sectional study.

In conclusion, increased age, male gender, obesity, and metabolic syndrome were found to be independent risk factors for suspected NAFLD in our nationally-representative sample of Korean adolescents. Vitamin D deficiency was associated with suspected NAFLD, independent of obesity and metabolic syndrome.

ACKNOWLEDGEMENTS

The authors thank the participants in the 2008–2014 Korean National Health and Nutrition Examination Survey (KNHANES).

Notes

^{Conflict of Interest} The authors have no financial conflicts of interest.

References

1. Shin YH, Kim KE, Lee C, Shin HJ, Kang MS, Lee HR, et al. High prevalence of vitamin D insufficiency or deficiency in young adolescents in Korea. Eur J Pediatr. 2012; 171:1475–1480.

2. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–281.

3. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005; 28:1228–1230.

4. Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes. 2015; 6:896–911.

5. Lim S, Kim MJ, Choi SH, Shin CS, Park KS, Jang HC, et al. Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr. 2013; 97:524–530.

6. Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. Hepatology. 2017; 65:2100–2109.

7. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016; 65:1038–1048.

8. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011; 9:85.

9. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2013; 23:792–798.

10. Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, Lee WY, et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J. 2013; 60:743–752.

11. Liangpunsakul S, Chalasani N. Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci. 2011; 56:2124–2129.

12. Katz K, Brar PC, Parekh N, Liu YH, Weitzman M. Suspected nonalcoholic Fatty liver disease is not associated with vitamin D status in adolescents after adjustment for obesity. J Obes. 2010; 2010:496829.

13. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43:69–77.

14. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999–2004. Gastroenterology. 2007; 133:1814–1820.

15. Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017; 64:319–334.

16. Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018; 61:135–149.

17. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr. 2008; 51:1–25.

18. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007; 8:299–306.

19. Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006. Am J Clin Nutr. 2011; 94:225–233.

20. Nam GE, Kim DH, Cho KH, Park YG, Han KD, Kim SM, et al. 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008–2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutr. 2014; 17:186–194.

21. Lee M, Larson R. The Korean ‘Examination Hell’: long hours of studying, distress, and depression. J Youth Adolesc. 2000; 29:249–271.

22. Kim JW, Lee KJ, Yang HR, Chang JY, Moon JS, Khang YH, et al. Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001–2014. BMC Public Health. 2018; 18:617.

23. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008; 93:S9–30.

24. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014; 15:6184–6223.

25. Seo JW. Nonalcoholic fatty liver disease in children. Korean J Pediatr Gastroenterol Nutr. 2011; 14:209–221.

26. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005; 82:1046–1051.

27. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr. 2009; 49:442–449.

28. Oh MS, Kim S, Jang JH, Park JY, Kang HS, Lee MS, et al. Associations among the degree of nonalcoholic fatty liver disease, metabolic syndrome, degree of obesity in children, and parental obesity. Pediatr Gastroenterol Hepatol Nutr. 2016; 19:199–206.

29. Park D, Kwon H, Oh SW, Joh HK, Hwang SS, Park JH, et al. Is vitamin D an independent risk factor of nonalcoholic fatty liver disease?: a cross-sectional study of the healthy population. J Korean Med Sci. 2017; 32:95–101.

30. Li L, Zhang L, Pan S, Wu X, Yin X. No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. Dig Dis Sci. 2013; 58:2376–2382.

31. Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013; 38:246–254.

32. Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014; 170:547–553.

33. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004; 79:820–825.

34. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology. 2012; 55:1103–1111.

35. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol. 2011; 55:415–425.

36. Fryar CD, Carroll MD, Ogden CL. Prevalence of obesity among children and adolescents: United States, trends 1963–1965 through 2009–2010. Hyattsville (MD): National Center for Health Statistics;2012.

37. Salmon J, Timperio A. Prevalence, trends and environmental influences on child and youth physical activity. Med Sport Sci. 2007; 50:183–199.

38. Janssen I, Leblanc AG. Systematic review of the health benefits of physical activity and fitness in school-aged children and youth. Int J Behav Nutr Phys Act. 2010; 7:40.

39. Robinson TN, Banda JA, Hale L, Lu AS, Fleming-Milici F, Calvert SL, et al. Screen media exposure and obesity in children and adolescents. Pediatrics. 2017; 140:S97–S101.

40. Papapostoli I, Lammert F, Stokes C. Short-term vitamin D supplementation improves hepatic steatosis as quantified by controlled attenuation parameter (CAP). Z Gastroenterol. 2015; 53:KG080.

TOOLS

Similar articles